Fresenius Targets Actavis With IP Suit Over Diprivan
By Dan Prochilo ( June 7, 2013, 1:45 PM EDT) -- Fresenius Kabi USA LLC launched a suit in Delaware federal court Thursday alleging Actavis Inc. and its subsidiary Watson Laboratories infringed four patents by attempting to market a generic form of the sedative and anesthetic Diprivan....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.